Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NM › ALBUQUERQUE › TRICORE INC.

TRICORE INC.

NPI: 1841962289 · ALBUQUERQUE, NM 87102 · Clinical Medical Laboratory · NPI assigned 10/04/2021

$35.84M
Total Medicaid Paid
1,842,696
Total Claims
1,779,585
Beneficiaries
310
Codes Billed
2022-07
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWATT, ELLA (CHIEF FINANCIAL OFFICER)
NPI Enumeration Date10/04/2021

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 366,390 $6.80M
2023 777,341 $15.19M
2024 698,965 $13.84M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80050 General health panel 57,698 57,214 $2.83M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 56,897 56,262 $1.70M
81513 11,500 11,189 $1.43M
80061 Lipid panel 101,455 100,287 $1.36M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 36,561 35,679 $1.34M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 36,574 35,691 $1.34M
88305 Level IV - Surgical pathology, gross and microscopic examination 12,849 12,217 $1.16M
80053 Comprehensive metabolic panel 111,436 104,917 $1.15M
36415 Collection of venous blood by venipuncture 156,060 144,386 $1.14M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 2,430 2,395 $1.05M
84443 Thyroid stimulating hormone (TSH) 59,715 58,628 $957K
83036 Hemoglobin; glycosylated (A1C) 89,597 88,452 $870K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 32,597 32,091 $805K
88307 2,946 2,697 $699K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 86,840 79,621 $644K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 5,240 4,935 $617K
80074 10,748 10,569 $518K
84439 56,589 55,712 $513K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,779 7,404 $500K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 13,218 12,818 $484K
86780 32,990 31,806 $477K
87481 11,533 11,220 $423K
84403 13,432 13,169 $368K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 9,869 9,772 $357K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 12,260 12,156 $335K
82728 24,255 23,859 $332K
86803 22,680 22,346 $328K
82607 21,589 21,312 $326K
82670 8,135 7,924 $321K
87086 Culture, bacterial; quantitative colony count, urine 38,185 36,598 $315K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4,325 4,047 $311K
84481 16,638 16,415 $287K
87902 974 958 $260K
88342 3,007 2,778 $256K
86480 3,926 3,869 $245K
85027 38,251 37,348 $242K
87522 Neg quan hep c or qual rna 5,357 5,236 $233K
84270 9,321 9,122 $213K
83550 23,661 23,321 $206K
88341 1,256 1,130 $202K
87505 1,657 1,616 $201K
83970 5,479 5,375 $200K
86003 1,967 1,708 $192K
82746 12,984 12,830 $191K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 4,470 4,413 $173K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 4,547 4,476 $171K
84153 9,532 9,400 $168K
83540 25,943 25,546 $168K
83001 8,795 8,686 $167K
87653 4,340 4,296 $159K
87340 14,225 14,020 $153K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1,015 1,001 $139K
86376 8,935 8,856 $136K
82570 25,768 25,045 $135K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1,011 991 $134K
86038 10,850 10,695 $132K
81511 896 880 $129K
86235 1,785 1,747 $126K
88185 444 420 $121K
87077 13,207 12,827 $121K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 217 217 $117K
88360 544 497 $113K
84702 7,078 5,740 $110K
88304 2,897 2,796 $110K
83880 2,914 2,839 $108K
86762 7,073 6,869 $106K
82043 18,816 18,510 $103K
88312 814 793 $97K
84144 4,476 4,277 $96K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 4,055 3,796 $96K
87486 2,643 2,591 $95K
87581 2,645 2,592 $95K
84480 6,517 6,405 $93K
84146 4,589 4,493 $92K
86140 17,582 16,449 $90K
87186 9,448 9,204 $87K
83002 4,542 4,487 $87K
86147 1,101 1,061 $82K
81514 390 356 $80K
86787 5,860 5,750 $80K
86146 1,028 1,011 $77K
80048 Basic metabolic panel (calcium, ionized) 9,474 9,127 $77K
86850 7,507 7,362 $76K
82105 4,224 4,162 $72K
86706 6,204 6,114 $70K
86696 3,174 3,129 $61K
81001 19,275 18,668 $59K
83735 8,595 7,763 $58K
82671 1,195 1,187 $55K
82784 4,688 4,576 $53K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 361 360 $53K
82274 3,135 3,097 $50K
86704 3,941 3,896 $50K
86160 2,120 2,025 $50K
85652 17,999 16,849 $48K
84425 1,256 1,241 $47K
87338 3,208 3,171 $47K
88313 446 424 $47K
87536 554 548 $46K
86431 8,077 7,992 $46K
85060 1,940 1,899 $46K
86200 3,243 3,211 $43K
86258 3,813 3,710 $43K
82627 1,881 1,861 $42K
80076 4,968 4,859 $41K
86364 3,831 3,786 $40K
86695 3,069 3,024 $40K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 829 819 $40K
86694 1,119 1,103 $40K
83525 3,302 3,278 $39K
80069 5,074 4,809 $37K
87529 900 887 $37K
82626 732 727 $37K
83690 4,217 4,137 $35K
83521 1,318 1,277 $35K
83520 461 452 $34K
84550 7,818 7,474 $34K
88173 287 257 $34K
88141 1,524 1,507 $34K
88112 829 704 $33K
83516 792 753 $32K
88302 1,014 983 $32K
84436 4,698 4,624 $32K
86665 915 863 $32K
86800 1,934 1,902 $31K
82248 6,210 5,831 $31K
82533 1,691 1,589 $31K
86708 2,404 2,369 $31K
84156 8,727 8,252 $31K
82024 752 695 $29K
85610 6,734 6,228 $29K
84154 1,603 1,590 $29K
82951 2,088 2,058 $28K
87081 4,053 4,002 $28K
85390 1,012 995 $27K
83498 612 607 $27K
83655 2,060 2,032 $27K
86225 1,978 1,948 $27K
82785 1,518 1,499 $26K
88184 461 437 $26K
88189 369 351 $24K
82397 1,562 1,546 $23K
87070 2,638 2,549 $23K
82378 1,239 1,055 $23K
86900 7,358 7,217 $22K
86901 7,322 7,181 $22K
81003 10,031 9,842 $22K
86304 1,093 1,010 $22K
80197 1,748 1,293 $22K
83615 3,629 3,317 $22K
81508 423 418 $21K
80164 1,493 1,375 $21K
G0452 Molecular pathology procedure; physician interpretation and report 728 668 $21K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 451 444 $21K
84630 592 586 $20K
82950 3,883 3,846 $19K
84207 444 440 $19K
85730 3,198 3,118 $19K
86334 961 931 $19K
84445 319 315 $18K
86039 1,590 1,565 $18K
82150 2,618 2,545 $17K
86141 1,304 1,294 $17K
82525 532 525 $17K
84482 390 389 $17K
82140 1,168 1,116 $16K
84100 3,712 3,333 $16K
86593 3,484 3,412 $16K
82977 2,041 1,961 $16K
84460 2,917 2,661 $15K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 716 713 $14K
82565 2,968 2,719 $14K
82247 2,917 2,483 $14K
84450 2,875 2,623 $14K
83993 707 699 $14K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 756 756 $14K
82550 2,077 1,786 $14K
84165 1,458 1,412 $14K
86341 165 160 $13K
83090 725 712 $13K
86705 1,044 1,033 $13K
81374 176 176 $12K
86381 479 472 $12K
84681 575 564 $12K
88311 735 645 $11K
83921 512 491 $11K
87205 2,583 2,491 $11K
85613 1,128 1,114 $11K
82040 2,190 1,961 $11K
82653 215 215 $10K
85379 947 931 $10K
87075 1,035 1,001 $9K
82542 131 128 $9K
80178 1,470 1,375 $9K
82390 797 790 $9K
81025 951 916 $9K
82330 623 611 $8K
88331 68 63 $8K
85046 1,388 1,358 $8K
86036 678 674 $7K
87076 729 713 $6K
82731 100 78 $6K
88309 25 24 $6K
83020 354 227 $6K
80177 478 470 $6K
82652 126 125 $6K
86300 336 239 $6K
87497 137 96 $6K
84466 443 433 $6K
86256 462 454 $6K
82103 349 344 $6K
86015 528 522 $5K
86664 329 326 $5K
83789 56 53 $5K
86765 376 365 $5K
82166 205 203 $5K
87799 118 96 $4K
86663 329 326 $4K
81270 59 57 $4K
88300 268 266 $4K
86735 311 299 $4K
84305 195 164 $4K
83519 39 36 $4K
81206 27 27 $4K
86689 208 201 $4K
86060 499 492 $4K
84484 296 283 $4K
82952 873 867 $4K
84590 149 145 $4K
84166 200 195 $3K
85732 439 433 $3K
88142 144 143 $3K
88365 27 25 $3K
82239 72 66 $3K
86632 45 44 $3K
86769 80 80 $3K
86709 278 276 $3K
85018 1,287 1,270 $3K
84432 52 46 $3K
86631 45 44 $3K
84520 774 759 $2K
82668 127 125 $2K
80165 97 97 $2K
87517 59 53 $2K
82947 707 700 $2K
84155 838 821 $2K
86644 102 91 $2K
G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician 66 66 $2K
82530 35 35 $2K
84134 137 136 $2K
85014 743 735 $2K
80175 134 132 $2K
86361 58 57 $2K
84132 517 507 $2K
G0475 Hiv antigen/antibody, combination assay, screening 138 135 $2K
86645 84 83 $1K
88344 16 13 $1K
82610 24 24 $1K
80156 105 100 $1K
86308 252 250 $1K
82360 51 51 $1K
84300 243 242 $1K
87535 13 13 $1K
83883 39 38 $1K
86008 13 12 $968.40
85306 55 55 $848.88
83721 69 69 $815.34
86301 40 37 $812.54
87209 46 45 $780.89
82310 281 279 $774.45
87147 84 80 $746.76
82172 12 12 $695.53
85660 138 130 $686.69
84446 26 25 $670.50
87449 40 39 $629.39
82164 12 12 $621.54
86870 40 40 $573.03
85303 43 43 $559.91
84080 15 15 $519.79
83695 15 15 $519.28
84478 112 74 $502.74
87102 59 57 $500.34
86255 28 28 $488.32
85300 39 39 $477.23
82374 221 220 $469.30
85384 56 52 $462.21
82435 219 218 $436.31
87206 79 75 $433.50
86778 13 13 $426.71
87177 46 45 $386.85
84075 212 211 $379.39
88291 13 12 $343.68
86618 12 12 $324.76
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 12 12 $291.72
84295 220 219 $265.57
86880 43 41 $249.48
82232 13 13 $234.70
87040 18 17 $199.80
82272 42 42 $185.69
82985 12 12 $171.53
81002 37 29 $149.41
82553 12 12 $109.02
80185 13 13 $104.03
82575 12 12 $102.75
82465 24 24 $94.20
82340 13 13 $60.69
81050 12 12 $52.44
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 13 13 $16.97
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result 50 49 $0.00
76098 58 57 $0.00